Protein S and protein C gene mutations in Japanese deep vein thrombosis patients

被引:98
作者
Kinoshita, S [1 ]
Iida, H [1 ]
Inoue, S [1 ]
Watanabe, K [1 ]
Kurihara, M [1 ]
Wada, Y [1 ]
Tsuda, H [1 ]
Kang, D [1 ]
Hamasaki, N [1 ]
机构
[1] Kyushu Univ Hosp, Dept Clin Chem & Lab Med, Higasi Ku, Fukuoka 8128582, Japan
关键词
deep vein thrombosis; protein S gene mutation; protein C gene mutation; factor V Leiden; Japanese thrombophilia;
D O I
10.1016/j.clinbiochem.2005.05.006
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Coagulation factor V Leiden has not been detected in Japanese patients suffering from thrombosis. Hitherto, the constitutional background of Japanese thrombotic patients has never been systematically examined. We have performed a systematic investigation to determine pathogenesis for deep vein thrombosis in a Japanese population. Design and methods: Routine coagulation and fibrinolysis tests were performed to determine the activities of protein S, protein C, antithrombin, plasminogen and fibrinogen. Gene analysis was performed in thrombotic patients having low activities of these factors. Results: Our study indicates that the frequency (19/85 = 0.22) of mutations of protein S gene in the Japanese patients was 5 - 10 times higher than that of mutations of protein S gene in Caucasian patients, and the frequency (8/85 = 0.09) of mutations of protein C gene was almost three times higher than that of Caucasian patients. The frequency of antithrombin gene mutation was similar in both populations. Conclusion: Our study reinforces that the genetic anomaly in the protein S/protein C anticoagulation system is an important risk factor for thrombophilia in the Japanese population. (c) 2005 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 36 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]   THE LUPUS ANTICOAGULANT - A DISEASE MARKER IN ANTINUCLEAR ANTIBODY NEGATIVE LUPUS THAT IS CROSS-REACTIVE WITH AUTOANTIBODIES TO DOUBLE-STRANDED DNA [J].
COLACO, CB ;
ELKON, KB .
ARTHRITIS AND RHEUMATISM, 1985, 28 (01) :67-74
[3]  
DAHLBACK B, 1995, THROMB HAEMOSTASIS, V74, P139
[4]   Genetic risk factors of venous thrombosis [J].
Franco, RF ;
Reitsma, PH .
HUMAN GENETICS, 2001, 109 (04) :369-384
[5]   Molecular mechanism of the dysfunction of protein S-Tokushima (Lys(155)->Glu) for the regulation of the blood coagulation system [J].
Hayashi, T ;
Nishioka, J ;
Suzuki, K .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1272 (03) :159-167
[6]   PROTEIN-S TOKUSHIMA - ABNORMAL-MOLECULE WITH A SUBSTITUTION OF GLU FOR LYS-155 IN THE 2ND EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF PROTEIN-S [J].
HAYASHI, T ;
NISHIOKA, J ;
SHIGEKIYO, T ;
SAITO, S ;
SUZUKI, K .
BLOOD, 1994, 83 (03) :683-690
[7]  
Hayashi Tatsuya, 1996, Polish Journal of Pharmacology, V48, P221
[8]   DEFICIENCIES OF COAGULATION-INHIBITING AND FIBRINOLYTIC PROTEINS IN OUTPATIENTS WITH DEEP-VEIN THROMBOSIS [J].
HEIJBOER, H ;
BRANDJES, DPM ;
BULLER, HR ;
STURK, A ;
TENCATE, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (22) :1512-1516
[9]   COMPLETE NUCLEOTIDE-SEQUENCE OF THE GENE FOR HUMAN HEPARIN COFACTOR-II AND MAPPING TO CHROMOSOMAL BAND-22Q11 [J].
HERZOG, R ;
LUTZ, S ;
BLIN, N ;
MARASA, JC ;
BLINDER, MA ;
TOLLEFSEN, DM .
BIOCHEMISTRY, 1991, 30 (05) :1350-1357
[10]  
HILLARP A, 1993, J BIOL CHEM, V268, P15017